Clinical trial
Atomoxetine, Diurnal Profiles of Cortisol and α-amylase, Possible Biological Markers of Treatment Success
NCT03075579 is registered in ClinicalTrials.gov with Praxis für kleine und grosse Leute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atomoxetine, Diurnal Profiles of Cortisol and α-amylase, Possible Biological Markers of Treatment Success
- Lead sponsor
- Praxis für kleine und grosse Leute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2016
- Completion date
- July 31, 2018
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
adhd